FdaApplication

NDA 020936

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAPOTEX INC
application_typeNDA
approval_date1999-02-16

Products (3)

ProductActive ingredientStrengthDosage form
PAXIL CRPAROXETINE HYDROCHLORIDEEQ 12.5MG BASETABLET, EXTENDED RELEASE;ORAL
PAXIL CRPAROXETINE HYDROCHLORIDEEQ 25MG BASETABLET, EXTENDED RELEASE;ORAL
PAXIL CRPAROXETINE HYDROCHLORIDEEQ 37.5MG BASETABLET, EXTENDED RELEASE;ORAL

3 products